Karen Beenken
Concepts (216)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Staphylococcus aureus | 38 | 2021 | 361 | 4.090 |
Why?
| Biofilms | 30 | 2021 | 206 | 3.310 |
Why?
| Bacterial Proteins | 26 | 2021 | 472 | 3.090 |
Why?
| Staphylococcal Infections | 21 | 2021 | 300 | 2.310 |
Why?
| Anti-Bacterial Agents | 18 | 2021 | 794 | 2.240 |
Why?
| Trans-Activators | 13 | 2021 | 162 | 1.990 |
Why?
| Osteomyelitis | 11 | 2021 | 128 | 1.890 |
Why?
| Gene Expression Regulation, Bacterial | 20 | 2021 | 252 | 1.690 |
Why?
| Chitosan | 7 | 2021 | 33 | 1.510 |
Why?
| Peptide Hydrolases | 9 | 2021 | 70 | 1.470 |
Why?
| Drug Delivery Systems | 3 | 2021 | 154 | 0.970 |
Why?
| Daptomycin | 6 | 2016 | 39 | 0.960 |
Why?
| Virulence Factors | 6 | 2021 | 96 | 0.850 |
Why?
| Bone Regeneration | 1 | 2021 | 64 | 0.820 |
Why?
| Protein Kinases | 3 | 2019 | 95 | 0.790 |
Why?
| Vancomycin | 7 | 2021 | 88 | 0.730 |
Why?
| Mutation | 20 | 2021 | 1432 | 0.700 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 4 | 2018 | 91 | 0.700 |
Why?
| Virulence | 12 | 2021 | 195 | 0.640 |
Why?
| Catheter-Related Infections | 7 | 2016 | 57 | 0.600 |
Why?
| Prosthesis-Related Infections | 2 | 2017 | 119 | 0.600 |
Why?
| Disease Models, Animal | 13 | 2021 | 1700 | 0.590 |
Why?
| Polymethyl Methacrylate | 2 | 2014 | 33 | 0.590 |
Why?
| Deoxyribonucleases | 3 | 2015 | 26 | 0.580 |
Why?
| Animals | 33 | 2021 | 14806 | 0.560 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2016 | 214 | 0.530 |
Why?
| Amikacin | 4 | 2018 | 18 | 0.520 |
Why?
| Delayed-Action Preparations | 2 | 2016 | 51 | 0.500 |
Why?
| Rabbits | 5 | 2021 | 462 | 0.500 |
Why?
| Mice | 25 | 2021 | 6403 | 0.490 |
Why?
| Xylitol | 1 | 2012 | 8 | 0.470 |
Why?
| Drug Carriers | 3 | 2017 | 79 | 0.450 |
Why?
| Coated Materials, Biocompatible | 3 | 2017 | 42 | 0.430 |
Why?
| Pseudomonas aeruginosa | 5 | 2017 | 90 | 0.430 |
Why?
| Bacteremia | 4 | 2017 | 102 | 0.400 |
Why?
| Epistasis, Genetic | 1 | 2010 | 35 | 0.400 |
Why?
| Microbial Sensitivity Tests | 9 | 2018 | 278 | 0.360 |
Why?
| Phenotype | 7 | 2021 | 842 | 0.320 |
Why?
| Lipoproteins | 2 | 2012 | 44 | 0.320 |
Why?
| Bacterial Outer Membrane Proteins | 1 | 2005 | 34 | 0.290 |
Why?
| Gram-Negative Bacteria | 1 | 2005 | 37 | 0.290 |
Why?
| Escherichia coli Proteins | 1 | 2005 | 100 | 0.270 |
Why?
| Carrier Proteins | 2 | 2005 | 373 | 0.260 |
Why?
| Polyethylene Glycols | 3 | 2021 | 98 | 0.240 |
Why?
| Membrane Proteins | 1 | 2005 | 390 | 0.240 |
Why?
| Gene Expression Profiling | 2 | 2006 | 1119 | 0.230 |
Why?
| RNA, Bacterial | 5 | 2011 | 62 | 0.220 |
Why?
| Extracellular Space | 4 | 2021 | 48 | 0.220 |
Why?
| Gentamicins | 1 | 2021 | 36 | 0.210 |
Why?
| X-Ray Microtomography | 1 | 2021 | 64 | 0.210 |
Why?
| Durapatite | 1 | 2021 | 29 | 0.210 |
Why?
| Proteomics | 3 | 2019 | 326 | 0.210 |
Why?
| Tissue Scaffolds | 1 | 2021 | 30 | 0.210 |
Why?
| Biocompatible Materials | 2 | 2021 | 65 | 0.210 |
Why?
| Endopeptidases | 1 | 2021 | 75 | 0.210 |
Why?
| Bacterial Infections | 2 | 2018 | 105 | 0.200 |
Why?
| Chronic Disease | 2 | 2014 | 630 | 0.200 |
Why?
| Repressor Proteins | 1 | 2021 | 171 | 0.190 |
Why?
| Bacterial Toxins | 3 | 2020 | 62 | 0.180 |
Why?
| Gold | 2 | 2018 | 161 | 0.180 |
Why?
| Biopolymers | 1 | 2018 | 18 | 0.170 |
Why?
| Ciprofloxacin | 1 | 2018 | 25 | 0.170 |
Why?
| Osteogenesis | 1 | 2021 | 379 | 0.170 |
Why?
| Coinfection | 1 | 2018 | 32 | 0.170 |
Why?
| Rifampin | 1 | 2018 | 53 | 0.170 |
Why?
| Fatty Acids, Monounsaturated | 1 | 2017 | 15 | 0.170 |
Why?
| Phosphatidylcholines | 1 | 2017 | 30 | 0.160 |
Why?
| RNA, Messenger | 4 | 2011 | 1276 | 0.160 |
Why?
| Bone and Bones | 1 | 2021 | 519 | 0.160 |
Why?
| Proteome | 1 | 2018 | 168 | 0.160 |
Why?
| Recombinases | 1 | 2016 | 8 | 0.150 |
Why?
| Peptides, Cyclic | 1 | 2016 | 42 | 0.150 |
Why?
| Nanoparticles | 1 | 2018 | 167 | 0.150 |
Why?
| Cephalosporins | 1 | 2016 | 33 | 0.150 |
Why?
| Sigma Factor | 1 | 2016 | 25 | 0.150 |
Why?
| Serine Endopeptidases | 2 | 2014 | 60 | 0.140 |
Why?
| Prostheses and Implants | 1 | 2015 | 63 | 0.140 |
Why?
| Genetic Loci | 1 | 2015 | 64 | 0.140 |
Why?
| Calcium Sulfate | 1 | 2014 | 8 | 0.130 |
Why?
| Amphotericin B | 1 | 2014 | 114 | 0.130 |
Why?
| Cysteine Endopeptidases | 1 | 2014 | 78 | 0.130 |
Why?
| Materials Testing | 1 | 2014 | 65 | 0.130 |
Why?
| Plant Extracts | 2 | 2012 | 205 | 0.120 |
Why?
| Hemolysin Proteins | 2 | 2011 | 17 | 0.120 |
Why?
| Quercus | 1 | 2012 | 8 | 0.120 |
Why?
| Protease Inhibitors | 2 | 2010 | 65 | 0.120 |
Why?
| Transcription Factors | 2 | 2014 | 640 | 0.120 |
Why?
| Magnetite Nanoparticles | 1 | 2012 | 24 | 0.120 |
Why?
| Debridement | 1 | 2012 | 57 | 0.120 |
Why?
| Bone Cements | 1 | 2012 | 41 | 0.120 |
Why?
| Radius | 1 | 2012 | 27 | 0.110 |
Why?
| Ellagic Acid | 1 | 2012 | 6 | 0.110 |
Why?
| RNA Stability | 1 | 2012 | 26 | 0.110 |
Why?
| Carotenoids | 1 | 2012 | 44 | 0.110 |
Why?
| Rosaceae | 1 | 2012 | 9 | 0.110 |
Why?
| Drug Resistance, Multiple, Bacterial | 2 | 2016 | 62 | 0.110 |
Why?
| Antifungal Agents | 1 | 2014 | 343 | 0.110 |
Why?
| Ribonuclease P | 1 | 2011 | 3 | 0.110 |
Why?
| Fluorodeoxyglucose F18 | 1 | 2012 | 203 | 0.110 |
Why?
| Surgical Wound Infection | 1 | 2012 | 131 | 0.110 |
Why?
| RNA-Binding Proteins | 1 | 2012 | 134 | 0.100 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2011 | 30 | 0.100 |
Why?
| Humans | 17 | 2021 | 53051 | 0.100 |
Why?
| Radiopharmaceuticals | 1 | 2012 | 256 | 0.100 |
Why?
| Polysaccharides, Bacterial | 1 | 2010 | 17 | 0.100 |
Why?
| Adhesins, Bacterial | 3 | 2012 | 32 | 0.100 |
Why?
| Anti-Infective Agents | 1 | 2011 | 109 | 0.100 |
Why?
| Mice, Inbred C57BL | 3 | 2020 | 2064 | 0.090 |
Why?
| Dose-Response Relationship, Drug | 1 | 2012 | 1572 | 0.080 |
Why?
| Adaptation, Physiological | 2 | 2006 | 103 | 0.080 |
Why?
| Male | 6 | 2014 | 28342 | 0.080 |
Why?
| Metalloendopeptidases | 2 | 2020 | 89 | 0.080 |
Why?
| Operon | 2 | 2016 | 40 | 0.070 |
Why?
| Membrane Fusion Proteins | 1 | 2005 | 1 | 0.070 |
Why?
| Multidrug Resistance-Associated Proteins | 1 | 2005 | 15 | 0.070 |
Why?
| Biological Transport, Active | 1 | 2005 | 30 | 0.070 |
Why?
| Chromatography, High Pressure Liquid | 2 | 2018 | 442 | 0.070 |
Why?
| Catheters | 2 | 2016 | 33 | 0.070 |
Why?
| Models, Biological | 2 | 2011 | 869 | 0.070 |
Why?
| Membrane Transport Proteins | 1 | 2005 | 66 | 0.070 |
Why?
| Arthritis, Infectious | 2 | 2003 | 47 | 0.070 |
Why?
| Osteoclasts | 2 | 2020 | 461 | 0.070 |
Why?
| Osteoblasts | 2 | 2020 | 535 | 0.070 |
Why?
| Protein Conformation | 1 | 2005 | 234 | 0.070 |
Why?
| Plankton | 1 | 2004 | 5 | 0.070 |
Why?
| Anaerobiosis | 1 | 2004 | 20 | 0.070 |
Why?
| Female | 7 | 2021 | 28985 | 0.070 |
Why?
| Colony Count, Microbial | 1 | 2004 | 72 | 0.070 |
Why?
| Genes, Bacterial | 1 | 2004 | 75 | 0.070 |
Why?
| Brain | 1 | 2013 | 1468 | 0.070 |
Why?
| Transcription, Genetic | 2 | 2003 | 465 | 0.070 |
Why?
| Hydrogen-Ion Concentration | 1 | 2004 | 194 | 0.060 |
Why?
| Models, Molecular | 1 | 2005 | 433 | 0.060 |
Why?
| Catheterization | 1 | 2004 | 109 | 0.060 |
Why?
| Escherichia coli | 1 | 2005 | 247 | 0.060 |
Why?
| Mice, Inbred BALB C | 1 | 2004 | 382 | 0.060 |
Why?
| Down-Regulation | 1 | 2004 | 402 | 0.060 |
Why?
| Musculoskeletal Diseases | 1 | 2003 | 45 | 0.060 |
Why?
| Up-Regulation | 1 | 2004 | 538 | 0.060 |
Why?
| Mannitol | 1 | 2021 | 14 | 0.050 |
Why?
| DNA Transposable Elements | 1 | 2021 | 96 | 0.050 |
Why?
| Titanium | 1 | 2021 | 53 | 0.050 |
Why?
| Disease Susceptibility | 1 | 2021 | 98 | 0.050 |
Why?
| Sepsis | 1 | 2021 | 241 | 0.040 |
Why?
| Genotype | 1 | 2020 | 637 | 0.040 |
Why?
| Tandem Mass Spectrometry | 1 | 2018 | 243 | 0.040 |
Why?
| Drug Combinations | 1 | 2017 | 138 | 0.040 |
Why?
| Teicoplanin | 1 | 2016 | 4 | 0.040 |
Why?
| Glycopeptides | 1 | 2016 | 14 | 0.040 |
Why?
| Aminoglycosides | 1 | 2016 | 22 | 0.040 |
Why?
| Freeze Drying | 1 | 2016 | 8 | 0.040 |
Why?
| Analysis of Variance | 1 | 2018 | 676 | 0.040 |
Why?
| Drug Compounding | 1 | 2016 | 28 | 0.040 |
Why?
| Polytetrafluoroethylene | 1 | 2016 | 39 | 0.040 |
Why?
| Drug Evaluation, Preclinical | 1 | 2016 | 163 | 0.040 |
Why?
| Acetates | 1 | 2016 | 50 | 0.040 |
Why?
| Drug Resistance, Bacterial | 1 | 2016 | 79 | 0.040 |
Why?
| Porifera | 1 | 2014 | 2 | 0.030 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2015 | 45 | 0.030 |
Why?
| Musculoskeletal System | 1 | 2014 | 18 | 0.030 |
Why?
| Point-of-Care Systems | 1 | 2015 | 68 | 0.030 |
Why?
| Cerebral Ventricles | 1 | 2013 | 28 | 0.030 |
Why?
| Plant Stems | 1 | 2012 | 11 | 0.030 |
Why?
| Animals, Outbred Strains | 1 | 2012 | 16 | 0.030 |
Why?
| Staphylococcal Protein A | 1 | 2012 | 7 | 0.030 |
Why?
| Photochemical Processes | 1 | 2012 | 10 | 0.030 |
Why?
| Color | 1 | 2012 | 29 | 0.030 |
Why?
| Plant Leaves | 1 | 2012 | 48 | 0.030 |
Why?
| Complementary Therapies | 1 | 2012 | 33 | 0.030 |
Why?
| Skin | 1 | 2016 | 443 | 0.030 |
Why?
| Light | 1 | 2012 | 76 | 0.030 |
Why?
| Molecular Imaging | 1 | 2012 | 61 | 0.030 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 76 | 0.030 |
Why?
| Chemical Fractionation | 1 | 2012 | 17 | 0.030 |
Why?
| Chromatin Immunoprecipitation | 1 | 2012 | 59 | 0.030 |
Why?
| Lasers | 1 | 2012 | 134 | 0.030 |
Why?
| Mice, Nude | 1 | 2012 | 278 | 0.030 |
Why?
| Biological Assay | 1 | 2012 | 59 | 0.030 |
Why?
| Antibodies | 1 | 2012 | 175 | 0.030 |
Why?
| Glycosylation | 1 | 2012 | 107 | 0.030 |
Why?
| Photoacoustic Techniques | 1 | 2012 | 88 | 0.030 |
Why?
| Microscopy, Confocal | 1 | 2012 | 119 | 0.030 |
Why?
| Hot Temperature | 1 | 2012 | 197 | 0.030 |
Why?
| Antibiotic Prophylaxis | 1 | 2012 | 70 | 0.030 |
Why?
| Fruit | 1 | 2012 | 140 | 0.030 |
Why?
| Hep G2 Cells | 1 | 2011 | 47 | 0.030 |
Why?
| Cell Death | 1 | 2012 | 240 | 0.030 |
Why?
| Chromatography, Liquid | 1 | 2012 | 243 | 0.030 |
Why?
| Small Molecule Libraries | 1 | 2011 | 74 | 0.030 |
Why?
| Blotting, Western | 1 | 2012 | 721 | 0.030 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 716 | 0.030 |
Why?
| Mass Spectrometry | 1 | 2012 | 324 | 0.020 |
Why?
| Positron-Emission Tomography | 1 | 2012 | 315 | 0.020 |
Why?
| Protein Binding | 1 | 2012 | 787 | 0.020 |
Why?
| Phenols | 1 | 2011 | 127 | 0.020 |
Why?
| Genetic Variation | 1 | 2011 | 262 | 0.020 |
Why?
| Acetoin | 1 | 2008 | 2 | 0.020 |
Why?
| Micrococcal Nuclease | 1 | 2008 | 7 | 0.020 |
Why?
| Butylene Glycols | 1 | 2008 | 12 | 0.020 |
Why?
| Genetic Complementation Test | 1 | 2008 | 54 | 0.020 |
Why?
| Inflammation | 1 | 2013 | 671 | 0.020 |
Why?
| Cell Line | 1 | 2012 | 1226 | 0.020 |
Why?
| Regulon | 1 | 2006 | 11 | 0.020 |
Why?
| Postoperative Complications | 1 | 2013 | 1082 | 0.020 |
Why?
| Cell Survival | 1 | 2008 | 695 | 0.020 |
Why?
| Rats | 1 | 2012 | 3596 | 0.020 |
Why?
| Gene Deletion | 1 | 2006 | 292 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 500 | 0.020 |
Why?
| RNA, Antisense | 1 | 2002 | 10 | 0.010 |
Why?
| Lipase | 1 | 2002 | 19 | 0.010 |
Why?
| Hemolysis | 1 | 2002 | 33 | 0.010 |
Why?
| Fibronectins | 1 | 2002 | 40 | 0.010 |
Why?
| Child | 1 | 2013 | 6942 | 0.010 |
Why?
| Collagen | 1 | 2002 | 234 | 0.010 |
Why?
| Incidence | 1 | 2003 | 1096 | 0.010 |
Why?
| Severity of Illness Index | 1 | 2003 | 1119 | 0.010 |
Why?
|
|
Beenken's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|